Literature DB >> 9497488

Adenosine decreases post-ischaemic cardiac TNF-alpha production: anti-inflammatory implications for preconditioning and transplantation.

D R Meldrum1, B S Cain, J C Cleveland, X Meng, A Ayala, A Banerjee, A H Harken.   

Abstract

Tumour necrosis factor-alpha (TNF-alpha) is an autocrine contributor to myocardial dysfunction and cardiomyocyte death in ischaemia-reperfusion injury (I/R), sepsis, chronic heart failure and cardiac allograft rejection. Cardiac resident macrophages, infiltrating leucocytes, and cardiomyocytes themselves produce TNF-alpha. Although adenosine reduces macrophage TNF-alpha production and protects myocardium against I/R, it remains unknown whether I/R induces an increase in cardiac TNF-alpha in a crystalloid-perfused model (in the absence of blood), and, whether adenosine decreases cardiac TNF-alpha and protects function after I/R. To study this, isolated rat hearts were crystalloid-perfused using the Langendorff method and subjected to I/R, with or without adenosine pretreatment. Post-ischaemic cardiac TNF-alpha (enzyme-linked immunosorbent assay and bioassay) and function were determined (Langendorff). I/R increased cardiac TNF-alpha and impaired myocardial function. Adenosine decreased cardiac TNF-alpha and improved post-ischaemic functional recovery. This study demonstrates that: first, I/R induces an increase in cardiac tissue TNF-alpha in a crystalloid-perfused model: second, adenosine decreases cardiac TNF-alpha and improves post-ischaemic myocardial function; third, decreased cardiac TNF-alpha may represent a mechanism by which adenosine protects myocardium; and fourth, adenosine-induced suppression of cardiac TNF-alpha may provide an anti-inflammatory link to preconditioning and have implications for cardiac allograft preservation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9497488      PMCID: PMC1364152          DOI: 10.1046/j.1365-2567.1997.00380.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

1.  Early and delayed preconditioning: differential mechanisms and additive protection.

Authors:  D R Meldrum; J C Cleveland; R T Rowland; A Banerjee; A H Harken; X Meng
Journal:  Am J Physiol       Date:  1997-08

2.  Preconditioning the human myocardium.

Authors:  D M Yellon; A M Alkhulaifi; W B Pugsley
Journal:  Lancet       Date:  1993-07-31       Impact factor: 79.321

3.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

4.  Cardiac release of cytokines and inflammatory responses in acute myocardial infarction.

Authors:  F J Neumann; I Ott; M Gawaz; G Richardt; H Holzapfel; M Jochum; A Schömig
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

5.  Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?

Authors:  R A Kloner; T Shook; K Przyklenk; V G Davis; L Junio; R V Matthews; S Burstein; M Gibson; W K Poole; C P Cannon
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

6.  Prodromal angina limits infarct size. A role for ischemic preconditioning.

Authors:  F Ottani; M Galvani; D Ferrini; F Sorbello; P Limonetti; D Pantoli; F Rusticali
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

Review 7.  Cardiac preconditioning. Induction of endogenous tolerance to ischemia-reperfusion injury.

Authors:  D R Meldrum; M B Mitchell; A Banerjee; A H Harken
Journal:  Arch Surg       Date:  1993-11

8.  Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

Authors:  T Yokoyama; L Vaca; R D Rossen; W Durante; P Hazarika; D L Mann
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

9.  Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration.

Authors:  S Kapadia; J Lee; G Torre-Amione; H H Birdsall; T S Ma; D L Mann
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

10.  Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain.

Authors:  D N Hart; J W Fabre
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  5 in total

Review 1.  The role of anti-cytokine therapy in the failing heart.

Authors:  A Deswal; A Misra; B Bozkurt
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

2.  Adenosine postconditioning protects against myocardial ischemia-reperfusion injury though modulate production of TNF-α and prevents activation of transcription factor NF-kappaB.

Authors:  Jian-Juan Ke; Feng-Xu Yu; Yan Rao; Yan-Lin Wang
Journal:  Mol Biol Rep       Date:  2010-04-09       Impact factor: 2.316

3.  Ischemia/reperfusion injury: The role of immune cells.

Authors:  Mozow Y Zuidema; Cuihua Zhang
Journal:  World J Cardiol       Date:  2010-10-26

4.  The interaction between myocardial depressant factors in endotoxemic cardiac dysfunction: role of TNF-alpha in TLR4-mediated ICAM-1 expression.

Authors:  Lihua Ao; Yong Song; David A Fullerton; Charles A Dinarello; Xianzhong Meng
Journal:  Cytokine       Date:  2007-08-01       Impact factor: 3.861

Review 5.  AMP deaminase 1 gene polymorphism and heart disease-a genetic association that highlights new treatment.

Authors:  Ryszard T Smolenski; Iwona Rybakowska; Jacek Turyn; Paweł Romaszko; Magdalena Zabielska; Anne Taegtmeyer; Ewa M Słomińska; Krystian K Kaletha; Paul J R Barton
Journal:  Cardiovasc Drugs Ther       Date:  2014-04       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.